Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UH3 Clinical Trial Optional)

Federal funding opportunity RFA-AR-25-014 from National Institutes of Health (Department of Health and Human Services).

Program funding history

Synopsis

Who can apply

• State governments
• City or township governments
• Native American tribal governments (Federally recognized)
• Independent school districts
• Small businesses
• Private institutions of higher education
• Public housing authorities/Indian housing authorities
• County governments
• For profit organizations other than small businesses
• Public and State controlled institutions of higher education
• Native American tribal organizations (other than Federally recognized tribal governments)
• Others (see text field entitled "Additional Information on Eligibility" for clarification)
• Special district governments
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education

Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

The official record

Similar grants

• Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
  PAR-27-011 · National Institutes of Health · closes November 2, 2028
• Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
  PAR-27-012 · National Institutes of Health · closes November 2, 2028
• Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
  PAR-27-013 · National Institutes of Health · closes November 2, 2028
• Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
  PAR-27-125 · National Institutes of Health
• Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
  PAR-25-296 · National Institutes of Health · closes October 19, 2027
• NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
  PAR-25-025 · National Institutes of Health · closes January 7, 2027